Trucheck Pragma
Commercial- Indications
- Lung cancer, Stomach cancer, Colon cancer, Pancreatic cancer, Prostate cancer, Breast cancer, Ovarian cancer
Company intelligence / Profile preview
Datar Cancer Genetics
Nasik, Maharashtra, Indiadatarpgx.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Commercial
01
Overview
Datar Cancer Genetics has developed several CE-marked blood-based diagnostic tests for early detection and management of various cancers. Their platforms have received two US FDA Breakthrough Device Designations for breast and prostate cancer screening. Clinical studies have included over 50,000 patients to date. Their technology enables non-invasive diagnosis when tissue biopsy is inconclusive or not feasible.
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsy diagnosticsMulti-analyte molecular profiling (NGS-based)Circulating Tumor Cell analysisProteomics
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborates with research institutes/hospitals worldwide including in the USA, UK, India & EU. Specific partners not named in public sources.
Beyond the preview
Go deeper on Datar Cancer Genetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Datar Cancer Genetics.